| pubmed-article:17605313 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17605313 | lifeskim:mentions | umls-concept:C0021655 | lld:lifeskim |
| pubmed-article:17605313 | lifeskim:mentions | umls-concept:C0599745 | lld:lifeskim |
| pubmed-article:17605313 | pubmed:issue | 6 Pt 2 | lld:pubmed |
| pubmed-article:17605313 | pubmed:dateCreated | 2007-7-3 | lld:pubmed |
| pubmed-article:17605313 | pubmed:abstractText | Lipid abnormalities such as obesity, increased circulating free fatty acid levels, and excess intramyocellular lipid accumulation are frequently associated with insulin resistance. These observations have prompted investigators to speculate that the accumulation of lipids in tissues not suited for fat storage (e.g., skeletal muscle and liver) is an underlying component of insulin resistance and the metabolic syndrome. We review the metabolic fates of lipids in insulin-responsive tissues and discuss the roles of specific lipid metabolites (e.g., ceramides, GM3 ganglioside, and diacylglycerol) as antagonists of insulin signaling and action. | lld:pubmed |
| pubmed-article:17605313 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17605313 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17605313 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17605313 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17605313 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17605313 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17605313 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17605313 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17605313 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17605313 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17605313 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:17605313 | pubmed:issn | 0029-6643 | lld:pubmed |
| pubmed-article:17605313 | pubmed:author | pubmed-author:SummersScott... | lld:pubmed |
| pubmed-article:17605313 | pubmed:author | pubmed-author:WangLi-PingLP | lld:pubmed |
| pubmed-article:17605313 | pubmed:author | pubmed-author:KnottsTrina... | lld:pubmed |
| pubmed-article:17605313 | pubmed:author | pubmed-author:HollandWillia... | lld:pubmed |
| pubmed-article:17605313 | pubmed:author | pubmed-author:HoehnKyle LKL | lld:pubmed |
| pubmed-article:17605313 | pubmed:author | pubmed-author:ChavezJose... | lld:pubmed |
| pubmed-article:17605313 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17605313 | pubmed:volume | 65 | lld:pubmed |
| pubmed-article:17605313 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17605313 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17605313 | pubmed:pagination | S39-46 | lld:pubmed |
| pubmed-article:17605313 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:17605313 | pubmed:meshHeading | pubmed-meshheading:17605313... | lld:pubmed |
| pubmed-article:17605313 | pubmed:meshHeading | pubmed-meshheading:17605313... | lld:pubmed |
| pubmed-article:17605313 | pubmed:meshHeading | pubmed-meshheading:17605313... | lld:pubmed |
| pubmed-article:17605313 | pubmed:meshHeading | pubmed-meshheading:17605313... | lld:pubmed |
| pubmed-article:17605313 | pubmed:meshHeading | pubmed-meshheading:17605313... | lld:pubmed |
| pubmed-article:17605313 | pubmed:meshHeading | pubmed-meshheading:17605313... | lld:pubmed |
| pubmed-article:17605313 | pubmed:meshHeading | pubmed-meshheading:17605313... | lld:pubmed |
| pubmed-article:17605313 | pubmed:meshHeading | pubmed-meshheading:17605313... | lld:pubmed |
| pubmed-article:17605313 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17605313 | pubmed:articleTitle | Lipid mediators of insulin resistance. | lld:pubmed |
| pubmed-article:17605313 | pubmed:affiliation | Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, Utah 84132, USA. | lld:pubmed |
| pubmed-article:17605313 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17605313 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:17605313 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17605313 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17605313 | lld:pubmed |
